These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21889251)

  • 1. Biological markers of cognition in prodromal Huntington's disease: a review.
    Papp KV; Kaplan RF; Snyder PJ
    Brain Cogn; 2011 Nov; 77(2):280-91. PubMed ID: 21889251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling longitudinal change in motor and cognitive processing speed in presymptomatic Huntington's disease.
    Maroof DA; Gross AL; Brandt J
    J Clin Exp Neuropsychol; 2011 Oct; 33(8):901-9. PubMed ID: 21644140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients.
    Ribaï P; Nguyen K; Hahn-Barma V; Gourfinkel-An I; Vidailhet M; Legout A; Dodé C; Brice A; Dürr A
    Arch Neurol; 2007 Jun; 64(6):813-9. PubMed ID: 17562929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of presymptomatic cognitive decline in Huntington's disease.
    Diamond R; White RF; Myers RH; Mastromauro C; Koroshetz WJ; Butters N; Rothstein DM; Moss MB; Vasterling J
    J Clin Exp Neuropsychol; 1992 Nov; 14(6):961-75. PubMed ID: 1452640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal functional magnetic resonance imaging of cognition in preclinical Huntington's disease.
    Wolf RC; Sambataro F; Vasic N; Wolf ND; Thomann PA; Landwehrmeyer GB; Orth M
    Exp Neurol; 2011 Oct; 231(2):214-22. PubMed ID: 21726553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive decline in prodromal Huntington Disease: implications for clinical trials.
    Paulsen JS; Smith MM; Long JD;
    J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1233-9. PubMed ID: 23911948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double blind evaluation of cognitive decline in a Norwegian cohort of asymptomatic carriers of Huntington's disease.
    van Walsem MR; Sundet K; Retterstøl L; Sundseth Ø
    J Clin Exp Neuropsychol; 2010 Jul; 32(6):590-8. PubMed ID: 19916101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early cognitive deficits in Swedish gene carriers of Huntington's disease.
    Robins Wahlin TB; Lundin A; Dear K
    Neuropsychology; 2007 Jan; 21(1):31-44. PubMed ID: 17201528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and psychiatric characterization of patients with Huntington's disease and their at-risk relatives.
    Soliveri P; Monza D; Piacentini S; Paridi D; Nespolo C; Gellera C; Mariotti C; Albanese A; Girotti F
    Neurol Sci; 2002 Sep; 23 Suppl 2():S105-6. PubMed ID: 12548365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive scores in carriers of Huntington's disease gene compared to noncarriers.
    Foroud T; Siemers E; Kleindorfer D; Bill DJ; Hodes ME; Norton JA; Conneally PM; Christian JC
    Ann Neurol; 1995 May; 37(5):657-64. PubMed ID: 7755361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WAIS-R features of preclinical Huntington's disease: implications for early detection.
    Robins Wahlin TB; Larsson MU; Luszcz MA; Byrne GJ
    Dement Geriatr Cogn Disord; 2010; 29(4):342-50. PubMed ID: 20389076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Everyday cognition in prodromal Huntington disease.
    Williams JK; Kim JI; Downing N; Farias S; Harrington DL; Long JD; Mills JA; Paulsen JS;
    Neuropsychology; 2015 Mar; 29(2):255-67. PubMed ID: 25000321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and neuropsychological characteristics of Huntington's disease: a review].
    Arango-Lasprilla JC; Iglesias-Dorado J; Lopera F
    Rev Neurol; 2003 Oct 16-31; 37(8):758-65. PubMed ID: 14593636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic criteria for Huntington's disease based on natural history.
    Reilmann R; Leavitt BR; Ross CA
    Mov Disord; 2014 Sep; 29(11):1335-41. PubMed ID: 25164527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex movement behaviour and progression of Huntington's disease.
    Andrich J; Saft C; Ostholt N; Müller T
    Neurosci Lett; 2007 Apr; 416(3):272-4. PubMed ID: 17321683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychometric study in Huntington disease].
    Pasquier F; Cabaret M; Petit H
    Encephale; 1993; 19(4):303-11. PubMed ID: 8275917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical onset of symptoms in Huntington disease: severe cognitive decline preceding chorea or other motor manifestations.
    Cooper DB; Ales G; Lange C; Clement P
    Cogn Behav Neurol; 2006 Dec; 19(4):222-4. PubMed ID: 17159620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.
    Peinemann A; Schuller S; Pohl C; Jahn T; Weindl A; Kassubek J
    J Neurol Sci; 2005 Dec; 239(1):11-9. PubMed ID: 16185716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive deficits predict poorer functional capacity in Huntington's disease: but what is being measured?
    Eddy CM; Rickards HE
    Neuropsychology; 2015 Mar; 29(2):268-73. PubMed ID: 25110931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proximity to clinical onset influences motor and cognitive performance in presymptomatic Huntington disease gene carriers.
    Farrow M; Chua P; Churchyard A; Bradshaw JL; Chiu E; Georgiou-Karistianis N
    Cogn Behav Neurol; 2006 Dec; 19(4):208-16. PubMed ID: 17159618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.